Founded by George W. Bush, the President's Emergency Plan for AIDS Relief was taken out of the list of agencies that lost ...

An HIV prevention pill that could provide a month of protection per tablet has been given the green light to proceed to pivotal trials to test its efficacy. Spotlight reports on new findings on the ...

Lenacapavir, new twice-yearly HIV injection, raises hope for pill-weary patients. Discordant couples, sex workers hail ‘game ...

Integrating people-centered HIV care with primary health care is essential to improving access, equity and health outcomes, but doing so successfully requires coordinated policies, digital ...

Kenya has been picked among nine countries for the trials of the new injectable HIV prevention drug that has been rolled out ...

The World Health Organization has approved the rollout of an injectable HIV preventive drug; Lenacapavir or LEN. The National ...

In a sweeping national overhaul of HIV prevention funding, the CDC chose to bypass local and statewide community organizations like AVOL Kentucky.

US approves twice-yearly injection for HIV prevention. What you need to know about lenacapavir by Andrew Owen, The Conversation edited by Lisa Lock, reviewed by Andrew Zinin Editors' notes ...

Colorado health providers cheer the approval but say the drug costs $14,000 per shot. Yeztugo is the first and only injectable HIV prevention medication.

The FDA has approved Yeztugo, the world’s first twice-a-year shot to prevent HIV infection, marking a significant advancement in HIV prevention. The new treatment is expected to be a game changer for ...

In two recent studies, this new shot reportedly nearly eliminated new infections in people at substantial risk of HIV.